Bengaluru to get Israeli innovation centre

DHNS
October 11, 2018

Bengaluru, Oct 11: India’s technology hub, Bengaluru, which is home to a large number of multinational research and development centres and startup hubs, will soon be home to yet another mega innovation facility from Israel.

Israel will set up an India-Israeli Innovation Centre (IIIC), the first startup incubation facility in India. This facility by Israel will be only its fourth in the world after the US, the UK and China. 

The facility, spread across 10,000 square feet, will be set up in the central business district and will be operated by startup hub MESH (Modiin Entrepreneurs’ Startup Hub).

Interacting with DH, MESH founder and CEO Moshe Porat said the startup incubator in Benglauru is a step towards achieving greater synergy between Indian and Israeli startup companies.

“We have many startup companies in India, especially in Bengaluru, involved in deep technology and they are looking at leveraging by aligning with global startups and incubation centres. We expect by starting MESH in Bengaluru, we can bring synergy in this endeavour,” he said.

Porat added that the India-Israeli Innovation Centre will give access to Israeli investors and frontier tech talent.

He said the incubation centre will be ready by mid-December and two more will be opened soon. “We are aligning our gameplan around government initiatives like Startup India and Digital India. Israel has also identified six cities for starting these kind of incubation centres,” he said.

Each incubation centre will have around Rs 2 crore investment. MESH is a startup hub started in 2014 and is located in Israeli municipality of Modiin.

Varadarajan Krish, who will head the incubation centres in India, said it will bring on board both Israeli and Indian educational institutions for collaboration and co-research.

“Israel’s Technion, Ben-Gurian and Tel Aviv Universities will join hands with IITs and IIIT in India. Also, it will team up with NITI Aayog and Atal Innovation Mission.

Federation of Indo-Israeli Chambers of Commerce vice chairman David Keynan said the innovation centre is one more move to connect the tech industry in both countries. “Porat is a long-time industry veteran in Israel, and his abilities will contribute to the centre’s success,” said Keynan.

Comments

Unknown
 - 
Thursday, 11 Oct 2018

How lower class people will be benefitted with this project..? Govt, NGO, MNC not doing anything to poor people rather than taking land from them

Suresh
 - 
Thursday, 11 Oct 2018

Wow. such a great news

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
April 17,2020

Mangaluru, Apr 17: Authorities in Dakshina Kannada have announced a fresh coronavirus positive case. The patient is a resident of Uppinangady in Puttur taluk.

With this the total number of covid-19 positive cases in this coastal district mounted to 13 even though most of the patients have recovered and returned home after treatment.

In past twelve days this is the first coronavirus case reported in the district.

It is learnt that the 39-year-old had been to Delhi. He was home quarantined for past few days. His throat swabs were tested positive for the deadly disease today.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 7,2020

Bengaluru, Feb 7: Karnataka's Directorate of Health and Family Welfare Services on Thursday issued guidelines for testing, isolation, hospital admission and discharge in view of the outbreak of Novel Coronavirus (nCoV) in Wuhan city of China, a virus that has infected nearly 20,000 globally and has killed more than 500 in China.

According to the guidelines, the sample of any passenger, whether symptomatic or asymptomatic, with a history of travel to or residence in Wuhan city of China in the last 14 days, has to be collected and tested.

And the sample of any health personnel, who develops symptoms of the virus after being associated with the infected persons, has to be collected.

The circular further says that the clinical sample of any suspect/probable case of nCoV will be sent to the laboratory confirmation and the case will be kept in isolation. If tested positive, the treatment has to be provided as per the existing guidelines.

The virus originated from Wuhan, a Chinese city, in December and has since then spread to various parts around the world.

China has imposed quarantine and travel restrictions, affecting the movement of 56 million people in more than a dozen cities, amid fears that the transmission rate will accelerate.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
July 31,2020

Mangaluru, July 31: Coronavirus related deaths in Dakshina Kannada continued to surge, with the district administration recording five more fatalities in a day, thus taking the tally to 155.

The district has recorded multiple deaths every day from July 1 to 31. A majority of the deaths are due to comorbid conditions.

Among the five deaths reported today, a 47-year-old man from Mangaluru, was admitted to private hospital on July 30, and breathed his last on the same day. He was suffering from ARDS, Type 1 respiratory failure, COPD, Type II DM, HTN and died due to cardiac arrest.

Another patient was a 75-year-old man from Bantwal, who was admitted to a private hospital on July 23, and passed away on July 30. He was suffering from acute coronary syndrome, pneumonia (ARDS), metabolic encephalopathy, acute kidney injury, systemic hypertension, and type 2 diabetes mellitus.

The third patient was a 63-year-old man from Mangaluru, who was admitted to a private hospital on July 18, and passed away on July 30. He was suffering from ARDS, septic shock, renal failure, and secondary bacterial infection.

The fourth patient was an 88-year-old woman from Davanagere, who was admitted to a private hospital on July 9, and passed away on July 30. She was suffering from septic shock, and secondary bacterial infection.

The fifth patient was a 75-year-old man from Mangaluru. He was admitted to Wenlock hospital on July 15, and passed away on July 30. He was suffering from refractory ARDS, septic shock, renal failure, acute coronary event, arrhythmias, pulmonary thromboembolism, and hemoperitoneum.

The district administration said that though the above patients contracted coronavirus, the exact cause of their deaths is being investigated by a team of experts and their report is awaited.

On the other hand, Dakshina Kannada district recorded a total of 204 fresh cases, taking the tally to 5,713. Among the 204 new cases are 75 primary contacts, 63 with influenza-like illness (ILI), and 14 with severe acute respiratory illness (SARI). As many as 52 cases are under investigation. As many as 70 patients were discharged on Friday from Wenlock as well as private hospitals.

As per the district health bulletin, a total of 40,706 samples have been tested so far and 34,993 out of them have tested negative. Among the 5,713 positive cases reported in the district, only 2,929 are currently active. As many as 2,631 persons have recovered and been discharged.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.